Latest CAPR reports update at 2024-05-14: 2024-Q1 ∙ 2023-Q4 ∙ 2023-Q1
  1. Home
  2. Stock quotes
  3. Capricor Therapeutics
  4. Financial Ratios
Capricor Therapeutics logo
Capricor Therapeutics CAPR
$ 5.42 0.93%
mail-toReport an Error

Capricor Therapeutics Financial Ratios 2011-2024 | CAPR

Annual Financial Ratios Capricor Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

P/E

 -7.0 -3.7 -4.1 -7.5 -0.7 -1.0 18.0 -2.2 -3.3 -12.2 -15.5 -2.7 -4.1

P/S

 6.2 42.5 336.6 330.2 5.7 9.2 16.4 10.1 7.7 15.9 273.4 25.9 14.6

EPS

 -0.8 -1.2 -0.9 -0.9 -2.1 -5.2 0.1 -1.0 -0.8 -0.5 -0.8 -0.0 -0.1

EV (Enterprise Value)

 177 M 137 M 57.5 M 76.2 M 6.09 M 15.7 M 42.7 M 60 M 54 M 87.9 M 142 M 5.29 M 19.3 M

EBITDA per Share

 -0.86 -1.19 -0.9 -0.87 -2.04 -5.16 -5.48 -9.08 -7.86 -5.11 -6.55 -28.8 -65.5

EV/EBITDA

 -2.1 -5.2 -0.2 -0.7 -3.0 -3.0 -3.7 -12.9 -20.3 -2.1 -3.8

PEG

 0.32 0.21 0.13 0.1 -0.01 0.0 0.16 0.09 0.06 -0.32 -0.27 -0.04 -0.13

P/B

 6.9 9.2 2.6 3.6 0.8 3.3 3.9 -10.1 -41.2 -12.2 -257.2 -30.3 23.8

P/CF

 -6.1 22.1 -4.9 -9.7 -0.8 -1.1 -3.1 -2.5 -3.9 98.5 -22.0 -2.3 -4.3

ROE %

 -98.61 -246.22 -63.83 -48.43 -111.73 -329.13 21.66 469.80 1246.14 99.49 1662.41 1131.43 -588.02

ROA %

 -37.95 -57.93 -48.45 -39.45 -68.76 -164.28 14.94 -100.32 -80.01 -45.60 -160.56 -833.74 -355.99

ROCE %

 -87.67 -112.03 -56.29 -43.26 -75.71 -191.78 -88.08 -122.55 -132.19 -82.07 -198.08 2347.89 -589.75

Current Ratio

 1.6 1.3 4.1 11.3 11.7 6.7 9.4 3.7 2.1 1.8 1.8 0.5 2.4

DSO

 - - - - 31.9 44.7 47.2 20.4 14.0 27.5 0.1 - -

DIO

 - - - - - - - - - - - - -

DPO

 - - - - - - - - - - - - -

Operating Cycle

 - - - - - - - - - - - - -

Cash Conversion Cycle

 - - - - - - - - - - - - -

All numbers in USD currency

Quarterly Financial Ratios Capricor Therapeutics

2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

EPS

 -0.31 - -0.25 -0.29 -0.31 - -0.26 -0.29 -0.32 - -0.17 -0.21 -0.23 - -0.2 -0.23 -0.3 - -0.43 -0.59 -0.75 - -1.35 -1.42 -0.14 - -0.12 -0.16 -0.17 - -0.29 -0.26 -0.26 - -0.18 -0.19 -0.23 - -0.13 -0.13 -0.1 - -0.15 -0.16 -0.14 - -0.01 -0.01 -0.02 - -0.03 -0.03 -0.03

EBITDA per Share

 -0.32 - -0.26 -0.3 -0.32 - -0.26 -0.3 -0.32 - -0.18 -0.22 -0.23 - -0.19 -0.23 -0.3 - -0.4 -0.57 -0.75 - -1.33 -1.41 -0.14 - -0.11 -0.15 -0.16 - -0.28 -0.25 -0.25 - -0.17 -0.19 -0.23 - -0.12 -0.13 -0.1 - -0.14 -0.15 -0.14 - -0.01 -0.02 -0.02 - -0.03 -0.02 -0.03

ROE %

 392.12 -37.41 -78.71 -477.49 -245.73 -110.99 -121.69 -91.09 -67.36 -39.09 -52.95 -56.12 -54.25 -33.61 -57.10 -66.73 -84.30 -90.25 -179.86 -245.98 -305.40 -258.50 -282.86 -217.61 -159.20 -87.95 45.28 202.87 350.93 356.93 639.16 788.16 973.72 921.83 946.54 689.02 410.87 68.63 357.52 621.71 900.89 2255.03 3386.46 4229.01 5056.71 3394.30 2806.29 1086.84 -632.61 -1764.05 -588.02 -588.02 -588.02

ROA %

 -70.22 -47.63 -59.45 -54.06 -50.29 -36.10 -45.22 -42.53 -42.18 -32.85 -44.14 -46.31 -44.49 -27.38 -41.84 -45.00 -53.35 -55.54 -100.27 -130.54 -156.72 -129.03 -145.83 -117.91 -94.65 -60.67 -89.12 -100.76 -104.44 -76.22 -94.34 -84.01 -78.43 -59.19 -70.51 -63.72 -55.54 -31.46 -59.36 -75.94 -94.02 -217.80 -1051.54 -1857.38 -2661.78 -2501.22 -2857.21 -2379.46 -1901.71 -1067.97 -355.99 -355.99 -355.99

ROCE %

 -440.77 -282.72 -303.80 -162.43 -110.08 -55.56 -66.32 -56.00 -50.82 -37.56 -49.92 -51.53 -48.73 -30.05 -45.98 -49.55 -58.75 -61.19 -113.39 -149.66 -181.53 -150.42 -168.48 -134.34 -105.39 -65.62 -103.44 -123.21 -133.37 -101.52 -131.40 -123.45 -122.24 -97.76 -118.01 -108.39 -96.49 -56.61 -99.48 -122.10 -148.25 178.56 523.01 910.34 1419.54 1267.45 1128.25 644.60 75.78 -389.32 -139.20 -105.96 -144.16

Current Ratio

 1.6 1.6 0.9 1.1 1.1 1.3 1.4 1.5 1.6 4.2 6.8 6.1 6.1 5.4 5.4 5.4 5.4 2.6 2.6 2.6 2.6 2.0 2.0 2.0 2.0 3.2 3.2 3.2 3.2 0.8 0.8 0.8 0.8 0.9 0.9 0.9 0.9 0.7 0.7 0.7 0.7 0.9 0.9 0.9 0.9 10.2 0.6 0.6 0.6 2.5 2.5 2.5 -

DSO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DIO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

DPO

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Operating Cycle

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Cash Conversion Cycle

 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency